FDA clears Sequel’s insulin delivery system in Type 2 diabetes

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 19 Oct, 11:05 UTC

With Twiist already available in Type 1 diabetes, Sequel has made the automated insulin delivery system available for the Type 2 population.

science

Sources

• T2FDA clears Sequel’s insulin delivery system in Type 2 diabetesBioPharma Dive / Healthcare Dive / MedTech Dive19 Oct, 11:05